FDA Staff Reviewers Cast Doubt on Safety and Efficacy of Popular Peptides, Contrasting with Health Chief’s Advocacy
Washington D.C. – A significant divergence has emerged between the findings of U.S. Food and Drug Administration (FDA) staff reviewers and the public pronouncements of Health Secretary Robert F. Kennedy,…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple





